Skip to main content

Table 2 Association between the miR-944 expression levels and clinicopathological characteristics of patients with cervical cancer

From: microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer

Features

No. (%)

miR-944 expression

P

(n = 66)

Low, n (%)

High, n (%)

No. of patients

66

41 (62.1)

25 (37.9)

 

Age

   

0.815

  < 45 years

20

12 (60.0)

8 (40.0)

 

  ≥ 45 years

46

29 (63.0)

17 (37.0)

 

Histological type

   

0.174

 ADC

7

6 (85.7)

1 (12.9)

 

 SCC

59

35 (59.3)

24 (40.7)

 

Tumor size

   

0.026

  < 4 cm

30

23 (76.7)

7 (23.3)

 

  ≥ 4 cm

36

18 (50.0)

18 (50.0)

 

FIGO stage

   

0.042

 IA-IIA

29

22 (75.9)

7 (24.1)

 

 IIB-IVB

37

19 (51.4)

18 (48.6)

 

Lymph node metastasis

   

0.030

 No

35

26 (74.3)

9 (25.7)

 

 Yes

31

15 (48.4)

16 (51.6)

 
  1. Abbreviation; FIGO International Federation of Gynecology; P, Chi-square p-value